- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Top Growth Stocks
U.S. Pharmaceuticals & Biotech Top Growth Stocks
Results
35
35 companies
Axsome Therapeutics
Market Cap: US$5.1b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$103.91
7D
0.2%
1Y
29.5%
Ardelyx
Market Cap: US$933.1m
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$4.19
7D
15.4%
1Y
-21.2%
Mereo BioPharma Group
Market Cap: US$438.8m
A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
MREO
US$2.87
7D
2.9%
1Y
-20.1%
Legend Biotech
Market Cap: US$6.7b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$35.91
7D
7.4%
1Y
-21.8%
ARS Pharmaceuticals
Market Cap: US$1.7b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$16.09
7D
-4.1%
1Y
85.8%
Soleno Therapeutics
Market Cap: US$4.2b
A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
SLNO
US$86.21
7D
0.5%
1Y
105.1%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.24
7D
-5.6%
1Y
36.2%
Evoke Pharma
Market Cap: US$5.4m
Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.
EVOK
US$2.69
7D
-5.0%
1Y
-58.1%
Achieve Life Sciences
Market Cap: US$114.2m
A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.
ACHV
US$2.26
7D
-40.5%
1Y
-49.9%
Vanda Pharmaceuticals
Market Cap: US$275.8m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
VNDA
US$4.89
7D
6.1%
1Y
-8.8%
CorMedix
Market Cap: US$917.0m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$11.79
7D
-25.0%
1Y
186.2%
aTyr Pharma
Market Cap: US$456.6m
A clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States.
ATYR
US$5.28
7D
3.3%
1Y
242.9%
Arcutis Biotherapeutics
Market Cap: US$1.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$13.76
7D
-4.9%
1Y
43.3%
Biofrontera
Market Cap: US$6.5m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.69
7D
10.5%
1Y
-16.9%
Invivyd
Market Cap: US$85.8m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States.
IVVD
US$0.72
7D
-3.8%
1Y
-34.4%
SIGA Technologies
Market Cap: US$465.8m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.49
7D
1.4%
1Y
-16.8%
XOMA Royalty
Market Cap: US$315.2m
Operates as a biotech royalty aggregator in the United States and the Asia Pacific.
XOMA
US$26.11
7D
-4.9%
1Y
0.8%
Neuphoria Therapeutics
Market Cap: US$13.3m
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia.
NEUP
US$7.02
7D
13.2%
1Y
n/a
Rhythm Pharmaceuticals
Market Cap: US$4.0b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$65.44
7D
2.8%
1Y
54.6%
Harmony Biosciences Holdings
Market Cap: US$1.8b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$32.03
7D
-0.09%
1Y
6.8%
Krystal Biotech
Market Cap: US$4.0b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
KRYS
US$141.35
7D
-0.8%
1Y
-20.4%
BeOne Medicines
Market Cap: US$29.1b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$244.32
7D
-8.5%
1Y
65.1%
Citius Pharmaceuticals
Market Cap: US$21.2m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$2.10
7D
75.0%
1Y
-82.7%
Vericel
Market Cap: US$2.1b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$41.46
7D
-1.0%
1Y
-7.7%
Journey Medical
Market Cap: US$162.4m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$7.04
7D
1.0%
1Y
36.7%
Day One Biopharmaceuticals
Market Cap: US$670.0m
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$6.73
7D
4.5%
1Y
-50.1%
Amicus Therapeutics
Market Cap: US$1.8b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$5.95
7D
5.1%
1Y
-39.3%
Evaxion
Market Cap: US$15.7m
A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.
EVAX
US$2.47
7D
-4.6%
1Y
-84.3%
Avadel Pharmaceuticals
Market Cap: US$857.6m
Operates as a biopharmaceutical company in the United States.
AVDL
US$8.81
7D
-8.2%
1Y
-36.6%
Arcturus Therapeutics Holdings
Market Cap: US$352.8m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.99
7D
-3.1%
1Y
-39.5%
Geron
Market Cap: US$878.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.40
7D
-7.9%
1Y
-67.9%
Scholar Rock Holding
Market Cap: US$3.2b
A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
SRRK
US$35.55
7D
-0.7%
1Y
357.5%
Verona Pharma
Market Cap: US$8.2b
A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
VRNA
US$90.07
7D
-5.3%
1Y
473.3%
Protagonist Therapeutics
Market Cap: US$3.1b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$50.69
7D
-6.9%
1Y
46.9%
Alector
Market Cap: US$142.0m
A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.
ALEC
US$1.50
7D
0.7%
1Y
-66.0%